Compare CCAP & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCAP | OFIX |
|---|---|---|
| Founded | 2015 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.6M | 637.2M |
| IPO Year | N/A | N/A |
| Metric | CCAP | OFIX |
|---|---|---|
| Price | $14.93 | $15.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $16.50 | ★ $21.50 |
| AVG Volume (30 Days) | 194.2K | ★ 206.2K |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | ★ 11.64% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.97 | N/A |
| Revenue | $172,891,000.00 | ★ $818,058,000.00 |
| Revenue This Year | N/A | $3.97 |
| Revenue Next Year | N/A | $5.84 |
| P/E Ratio | $15.48 | ★ N/A |
| Revenue Growth | N/A | ★ 4.31 |
| 52 Week Low | $13.03 | $10.24 |
| 52 Week High | $20.19 | $20.48 |
| Indicator | CCAP | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 62.34 | 54.77 |
| Support Level | $14.15 | $15.51 |
| Resistance Level | $15.13 | $16.26 |
| Average True Range (ATR) | 0.29 | 0.54 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 88.44 | 72.17 |
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.